Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|February 1, 2017
Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related ToxicityS Hamzic, D Kummer, S Milesi, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort studyM Joerger, C Schaer-Thuer, D Koeberle, et al.
European Journal of Clinical Pharmacology|June 27, 2006
Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteersM Joerger, T M Bosch, V D Doodeman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2010
Predictors of state-of-the-art management of early breast cancer in SwitzerlandS Ess, M Joerger, H Frick, et al.
British Journal of Clinical Pharmacology|January 13, 2015
Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968)M Joerger, D Hess, A Delmonte, et al.
Prostate Cancer and Prostatic Diseases|September 15, 2005
Hypertriglyceridemia as a possible risk factor for prostate cancerL Wuermli, M Joerger, S Henz, et al.
Analytical and Bioanalytical Chemistry|June 14, 2005
Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometryE E M Brouwers, M M Tibben, M Joerger, et al.
Pageof 5